Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 22

Sort by

Sort Order Select

Journal Articles

GATA1 Insufficiencies in Dysmegakaryopoiesis of Myelodysplastic Syndromes/Neoplasms

Fuhui Li, Yudi Zhang, Chengwen Li, Qi Sun, Jinqin Liu, Tiejun Qin, Zefeng Xu, Bing Li, Shiqiang Qu, Lijuan Pan, Qingyan Gao, Meng Jiao, Robert Peter Gale, Zhijian Xiao

Blood (2024) 144 (Supplement 1): 6734.

https://doi.org/10.1182/blood-2024-200761

Published: 2024

Journal Articles

Impact of the 15-Item Frailty Scale in IPSS-R/IPSS-M Subgroup of Patients (Pts) with Myelodysplastic Syndromes (MDS)

Xin Wang, Tiejun Qin, Zefeng Xu, Shiqiang Qu, Bing Li, Li Juan Pan, Qingyan Gao, Meng Jiao, Jinying Zhao, Wenjun Xie, Robert Peter Gale, Zhijian Xiao

Blood (2024) 144 (Supplement 1): 6729.

https://doi.org/10.1182/blood-2024-199104

Published: 2024

Journal Articles

Factors Associated with Progression to Overt Acute Myeloid Leukemia in NPM1 -Mutated Myeloid Neoplasms with Less Than 10% Blasts

Jingye Gong, Tiejun Qin, Zefeng Xu, Bing Li, Shiqiang Qu, Lijuan Pan, Qingyan Gao, Meng Jiao, Robert Peter Gale, Zhijian Xiao

Blood (2024) 144 (Supplement 1): 2871.

https://doi.org/10.1182/blood-2024-212110

Published: 2024

Journal Articles

U2AF1 S34F Mutation Promote Megakaryopoiesis and Fibrogenesis in MDS

Wenjun Zhang, Jinqin Liu, Lin Yang, Yiru Yan, Tiejun Qin, Zefeng Xu, Gang Huang, Bing Li, Zhijian Xiao

Blood (2023) 142 (Supplement 1): 5685.

https://doi.org/10.1182/blood-2023-185678

Published: 2023

Journal Articles

Comparison of the 2022 ICC and Who Classification Systems of Myelodysplastic Neoplasms

Junying Wu, Yudi Zhang, Tiejun Qin, Zefeng Xu, Shiqiang Qu, Li Juan Pan, Robert Peter Gale, Bing Li, Zhijian Xiao

Blood (2023) 142 (Supplement 1): 1875.

https://doi.org/10.1182/blood-2023-184604

Published: 2023

Journal Articles

Validation of the 5 th Edition of the World Health Organization Classification of Myelodysplastic Neoplasms on 852 Consecutive De Novo Patients from a Single Institute

Yudi Zhang, Junying Wu, Tiejun Qin, Zefeng Xu, Shiqiang Qu, Lijuan Pan, Bing Li, Huijun Wang, Xin Yan, Jingye Gong, Robert Peter Gale, Zhijian Xiao

Blood (2022) 140 (Supplement 1): 1343–1345.

https://doi.org/10.1182/blood-2022-160131

Published: 2022

Journal Articles

IPSS-M Is More Powerful for MDS Patients Older Than 60 Years Old

Junying Wu, Yudi Zhang, Tiejun Qin, Zefeng Xu, Shiqiang Qu, Lijuan Pan, Bing Li, Qingyan Gao, Robert Peter Gale, Zhijian Xiao

Blood (2022) 140 (Supplement 1): 4092–4093.

https://doi.org/10.1182/blood-2022-165083

Published: 2022

Journal Articles

Mutational Landscape, Clonal Evolution and Prognostic Effect of Non-Driver Mutations during Disease Progression of Primary Myelofibrosis

Xin Yan, Zefeng Xu, Shiqiang Qu, Tiejun Qin, Gang Huang, Zhijian Xiao, Bing Li

Blood (2022) 140 (Supplement 1): 3965–3967.

https://doi.org/10.1182/blood-2022-165185

Published: 2022

Journal Articles

Unique Clinical Features and Mutation Profile in De Novo Myelodysplastic Syndromes with MF-1 and a Proposed Model for Distinguishing MDS with MF-2/3 from TN-PMF Based on Clinical and Genetic Covariates

Junying Wu, Wenjun Zhang, Peihong Zhang, Tiejun Qin, Zefeng Xu, Qi Sun, Yujiao Jia, Shiqiang Qu, Bing Li, Huijun Wang, Lijuan Pan, Jinqin Liu, Yudi Zhang, Xin Yan, Robert Peter Gale, Zhijian Xiao

Blood (2022) 140 (Supplement 1): 4058–4059.

https://doi.org/10.1182/blood-2022-163019

Published: 2022

Journal Articles

Molecular Biomarker Analyses for Exploring the Therapeutic Mechanism of Lemzoparlimab and Azacitidine (AZA) in Newly Diagnosed Higher Risk Myelodysplastic Syndrome (HR-MDS)

Blood (2022) 140 (Supplement 1): 8821–8822.

https://doi.org/10.1182/blood-2022-163880

Published: 2022

Journal Articles

Clonal Architecture Analysis of TET2 Identified Distinct Origins in Myelodysplastic Syndromes

Zhongxun Shi, MD, Bing Li, MD, Tiejun Qin, MD, Zefeng Xu, MD, Lijuan Pan, MD, Shiqiang Qu, MD, Gang Huang, PhD, Zhijian Xiao, MD

Blood (2020) 136 (Supplement 1): 18.

https://doi.org/10.1182/blood-2020-139329

Published: 2020

Journal Articles

Impact of U2AF1 Mutations on Clinical Characteristics and RNA Splicing in Myelodysplastic Syndromes (MDS)

Bing Li, MD, Jinqin Liu, Tiejun Qin, Zefeng Xu, MD, Gang Huang, PhD, Zhijian Xiao, MD

Blood (2019) 134 (Supplement_1): 2979.

https://doi.org/10.1182/blood-2019-126346

Published: 2019

Journal Articles

Clinical Features and Biological Implications of U2AF1 Mutations in Myelodysplastic Syndromes

Bing Li, Jinqin Liu, Yujiao Jia, MD, Tiejun Qin, Zefeng Xu, MD, Yue Zhang, MD PhD, Gang Huang, PhD, Zhijian Xiao

Blood (2017) 130 (Supplement 1): 586.

https://doi.org/10.1182/blood.V130.Suppl_1.586.586

Published: 2017

Journal Articles

Non-Driver Mutations Profile Identified By a 206-Gene NGS Panel in Patients with Primary Myelofibrosis and Post-Polycythaemic/Essential Thromocythaemia Myelofibrosis in a Single Center from China

Bing Li, MD, Lei Zhang, MD, Jie Bai, MD PhD, Zefeng Xu, MD, Tiejun Qin, Yue Zhang, MD, Jinqin Liu, Gang Huang, PhD, Zhijian Xiao, MD

Blood (2016) 128 (22): 1942.

https://doi.org/10.1182/blood.V128.22.1942.1942

Published: 2016

Journal Articles

Colony-Forming Unit Cell (CFU-C) Assays in Myelodysplastic Syndrome

Bing Li, MD, Jinqin Liu, Shiqiang Qu, MD, Robert Peter Gale, MD PhD DSc, Ruixian Xing, Tiejun Qin, Yue Zhang, MD, Zefeng Xu, MD, Liwei Fang, Hongli Zhang, MD, Lijuan Pan, Naibo Hu, Gang Huang, PhD, Zhijian Xiao, MD

Blood (2015) 126 (23): 2874.

https://doi.org/10.1182/blood.V126.23.2874.2874

Published: 2015

Journal Articles

A Novel Erythroid Regulator MLF1IP Promotes Proliferation in Mice By Regulating Cell Cycle

Tianjiao Zhang, MD, Xiaotang Ma, PhD, Bing Li, MD, Gang Huang, PhD, Robert Peter Gale, MD PhD DSc, Yue Zhang, MD, Zefeng Xu, MD, Tiejun Qin, Josef T. Prchal, MD, Zhijian Xiao, MD

Blood (2015) 126 (23): 2835.

https://doi.org/10.1182/blood.V126.23.2835.2835

Published: 2015

Journal Articles

Impact of Megakaryocyte Morphology on Prognosis of Persons with Myelodysplastic Syndromes

Gege Feng, MD, Wen Cui, Wenyu Cai, Tiejun Qin, Yue Zhang, MD, Zefeng Xu, MD, Liwei Fang, Hongli Zhang, MD, Lijuan Pan, Naibo Hu, Bing Li, MD, Zhijian Xiao, MD

Blood (2015) 126 (23): 2876.

https://doi.org/10.1182/blood.V126.23.2876.2876

Published: 2015

Journal Articles

Prognostic Impact of Splenomegaly on Survival of Chinese with Primary Myelofibrosis

Jingya Wang, Junqing Xu, Robert Peter Gale, MD PhD DSc, FACP, Zefeng Xu, MD, Bing Li, Tiejun Qin, Yue Zhang, Liwei Fang, Hongli Zhang, Lijuan Pan, Shiqiang Qu, Peihong Zhang, Zhijian Xiao, MD

Blood (2014) 124 (21): 3210.

https://doi.org/10.1182/blood.V124.21.3210.3210

Published: 2014

Journal Articles

Molecular Aberrations of Chronic Neutrophilic Leukemia: The CSF3R and SETBP1 Mutations

Yajuan Cui, Master, Bing Li, Robert Peter Gale, MD PhD DSc, FACP, Qian Jiang, Zefeng Xu, MD, Tiejun Qin, Peihong Zhang, Yue Zhang, Zhijian Xiao, MD

Blood (2014) 124 (21): 5578.

https://doi.org/10.1182/blood.V124.21.5578.5578

Published: 2014

Journal Articles

Unique features of primary myelofibrosis in Chinese

Zefeng Xu, Robert Peter Gale, Yue Zhang, Tiejun Qin, Huishu Chen, Peihong Zhang, Tianjiao Zhang, Liu Liu, Shiqiang Qu, Zhijian Xiao

Blood (2012) 119 (11): 2469–2473.

https://doi.org/10.1182/blood-2011-11-389866

Published: 2012

NARROW

GATA1 Insufficiencies in Dysmegakaryopoiesis of Myelodysplastic Syndromes/Neoplasms

Impact of the 15-Item Frailty Scale in IPSS-R/IPSS-M Subgroup of Patients (Pts) with Myelodysplastic Syndromes (MDS)

Factors Associated with Progression to Overt Acute Myeloid Leukemia in NPM1 -Mutated Myeloid Neoplasms with Less Than 10% Blasts

U2AF1 S34F Mutation Promote Megakaryopoiesis and Fibrogenesis in MDS

Comparison of the 2022 ICC and Who Classification Systems of Myelodysplastic Neoplasms

Validation of the 5 th Edition of the World Health Organization Classification of Myelodysplastic Neoplasms on 852 Consecutive De Novo Patients from a Single Institute

IPSS-M Is More Powerful for MDS Patients Older Than 60 Years Old

Mutational Landscape, Clonal Evolution and Prognostic Effect of Non-Driver Mutations during Disease Progression of Primary Myelofibrosis

Unique Clinical Features and Mutation Profile in De Novo Myelodysplastic Syndromes with MF-1 and a Proposed Model for Distinguishing MDS with MF-2/3 from TN-PMF Based on Clinical and Genetic Covariates

Molecular Biomarker Analyses for Exploring the Therapeutic Mechanism of Lemzoparlimab and Azacitidine (AZA) in Newly Diagnosed Higher Risk Myelodysplastic Syndrome (HR-MDS)

Clonal Architecture Analysis of TET2 Identified Distinct Origins in Myelodysplastic Syndromes

Impact of U2AF1 Mutations on Clinical Characteristics and RNA Splicing in Myelodysplastic Syndromes (MDS)

Clinical Features and Biological Implications of U2AF1 Mutations in Myelodysplastic Syndromes

Non-Driver Mutations Profile Identified By a 206-Gene NGS Panel in Patients with Primary Myelofibrosis and Post-Polycythaemic/Essential Thromocythaemia Myelofibrosis in a Single Center from China

Colony-Forming Unit Cell (CFU-C) Assays in Myelodysplastic Syndrome

A Novel Erythroid Regulator MLF1IP Promotes Proliferation in Mice By Regulating Cell Cycle

Impact of Megakaryocyte Morphology on Prognosis of Persons with Myelodysplastic Syndromes

Prognostic Impact of Splenomegaly on Survival of Chinese with Primary Myelofibrosis

Molecular Aberrations of Chronic Neutrophilic Leukemia: The CSF3R and SETBP1 Mutations

Unique features of primary myelofibrosis in Chinese

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only